Discontinued — last reported Q2 '20

Current Liabilities

Lease Liability Payments - Remainder of Fiscal Year

Merck & Co. Lease Liability Payments - Remainder of Fiscal Year increased by 1.8% to $335.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $329.00M to $335.00M. Over 5 years (FY 2020 to FY 2025), Lease Liability Payments - Remainder of Fiscal Year shows relatively stable performance with a -0.1% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2019
Last reportedQ2 2020
Metric ID: lease_liability_payments_remainder_fiscal_year

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$336.00M$323.00M$325.00M$329.00M$335.00M
QoQ Change-3.9%+0.6%+1.2%+1.8%
YoY Change-3.9%+0.6%+1.2%+1.8%
Range$323.00M$336.00M
CAGR-0.3%
Avg YoY Growth-0.0%
Median YoY Growth+0.9%
Current Streak3 quarters growth

Lease Liability Payments - Remainder of Fiscal Year at Other Companies

Frequently Asked Questions

What is Merck & Co.'s lease liability payments - remainder of fiscal year?
Merck & Co. (MRK) reported lease liability payments - remainder of fiscal year of $335.00M in Q4 2025.
How has Merck & Co.'s lease liability payments - remainder of fiscal year changed year-over-year?
Merck & Co.'s lease liability payments - remainder of fiscal year increased by 1.8% year-over-year, from $329.00M to $335.00M.
What is the long-term trend for Merck & Co.'s lease liability payments - remainder of fiscal year?
Over 5 years (2020 to 2025), Merck & Co.'s lease liability payments - remainder of fiscal year has grown at a -0.1% compound annual growth rate (CAGR), from $336.00M to $335.00M.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.